Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.9903
-0.0297 (-2.91%)
At close: Feb 11, 2026, 4:00 PM EST
0.9904
+0.0001 (0.01%)
After-hours: Feb 11, 2026, 7:04 PM EST

Bio Green Med Solution Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.080.040.42---
Revenue Growth (YoY)
9.46%-89.76%----
Cost of Revenue
1.746.5618.72---
Gross Profit
-1.66-6.52-18.3---
Selling, General & Admin
7.425.396.727.387.465.88
Research & Development
0.10.090.4320.2714.934.76
Operating Expenses
7.515.497.1527.6622.3910.64
Operating Income
-9.17-12-25.45-27.66-22.39-10.64
Interest & Investment Income
0.050.010.270.210.020.04
Currency Exchange Gain (Loss)
-0.09-0.05-0.410.230.040.02
Other Non Operating Income (Expenses)
0.020.050.051.30.140.89
EBT Excluding Unusual Items
-9.19-11.99-25.55-25.92-22.19-9.68
Pretax Income
-4.24-11.99-25.55-25.92-22.19-9.68
Income Tax Expense
1.2-0.78-3-4.72-3.73-1.24
Earnings From Continuing Operations
-5.44-11.21-22.56-21.2-18.46-8.45
Net Income
-5.44-11.21-22.56-21.2-18.46-8.45
Preferred Dividends & Other Adjustments
1.54-0.20.20.23.98
Net Income to Common
-6.97-11.21-22.76-21.4-18.66-12.42
Shares Outstanding (Basic)
10----
Shares Outstanding (Diluted)
10----
EPS (Basic)
-6.73-502.46----
EPS (Diluted)
-6.73-502.46----
Free Cash Flow
-6.09-7.99-16.12-20.83-18.57-8.03
Free Cash Flow Per Share
-5.88-358.07----
Operating Margin
-11324.69%-27916.28%-6060.24%---
Profit Margin
-8609.88%-26074.42%-5418.10%---
Free Cash Flow Margin
-7522.22%-18581.40%-3837.62%---
EBITDA
-9.17-12-25.42-27.62-22.35-10.62
D&A For EBITDA
00.010.030.030.040.02
EBIT
-9.17-12-25.45-27.66-22.39-10.64
Revenue as Reported
0.080.040.42---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.